Overall ADR, n (%) [95% CI]
|
46 (53.5) [42.4, 64.3]
|
50 (58.1) [47.0, 68.7]
|
0.645
|
ADR for screening indication, n (%) [95% CI]
|
16/33 (48.5) [30.8, 66.5]
|
30/48 (62.5) [47.4, 76.0]
|
0.257
|
ADR for surveillance indication, n (%) [95% CI]
|
30/53 (56.6) [42.3, 70.2]
|
20/38 (52.6) [35.8, 69.0]
|
0.831
|
Right colon ADR, n (%) [95% CI]
|
32 (37.2) [27.0, 48.3]
|
30 (34.9) [24.9, 45.9]
|
0.874
|
Proximal colon ADR, n (%) [95% CI]
|
39 (45.3) [34.6, 56.5]
|
38 (44.2) [33.5, 55.3]
|
1.000
|
Distal colon ADR, n (%) [95% CI]
|
22 (25.6) [16.8, 36.1]
|
27 (31.4) [21.8, 42.3]
|
0.499
|
Overall advanced ADR, n (%) [95% CI]
|
5 (5.8) [1.9, 13.1]
|
5 (5.8) [1.9, 13.1]
|
1.000
|
Proximal colon advanced ADR, n (%) [95% CI]
|
2 (2.3) [0.3, 8.2]
|
2 (2.3) [0.3, 8.2]
|
1.000
|
Overall MAP (SD)
|
1.2 (1.4)
|
1.4 (1.8)
|
0.394
|
Right colon MAP (SD)
|
0.6 (1.0)
|
0.6 (1.1)
|
0.827
|
Proximal colon MAP (SD)
|
0.8 (1.2)
|
0.9 (1.4)
|
0.680
|
Right colon mean number of adenoma and HP (SD)
|
0.9 (1.1)
|
0.8 (1.1)
|
0.739
|
Proximal colon mean number of adenoma and HP (SD)
|
1.3 (1.5)
|
1.2 (1.4)
|
0.797
|
PHP-DR, n (%) [95% CI]
|
23 (26.7) [17.8, 37.4]
|
26 (30.2) [20.8, 41.1]
|
0.736
|